Page last updated: 2024-10-22

ambroxol and Edema, Pulmonary

ambroxol has been researched along with Edema, Pulmonary in 1 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Research Excerpts

ExcerptRelevanceReference
"Anti-asthmatic agents could alleviate pulmonary edema through upregulating the expression of AQP1 and AQP5 in mouse lungs that have OVA-induced asthma."1.38Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma. ( Bai, C; Dong, C; Huang, H; Li, B; Ma, Z; Wang, G; Wang, X; Xiao, K, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, C1
Wang, G1
Li, B1
Xiao, K1
Ma, Z1
Huang, H1
Wang, X1
Bai, C1

Other Studies

1 other study available for ambroxol and Edema, Pulmonary

ArticleYear
Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma.
    Respiratory physiology & neurobiology, 2012, Apr-15, Volume: 181, Issue:1

    Topics: Ambroxol; Animals; Anti-Asthmatic Agents; Aquaporin 1; Aquaporin 5; Asthma; Dexamethasone; Lung; Mic

2012